ArticleBlood cancer discovery2025

Beyond Trial and Error: A Mathematical Model Wrangles DLBCL Heterogeneity Toward Optimizing Combination Therapy.

Jordan S Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.